WhitTier Trust Company’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-80
Closed 1020
2020
Q3
$0 Hold
80
﹤0.01% 991
2020
Q2
$0 Hold
80
﹤0.01% 1019
2020
Q1
$0 Hold
80
﹤0.01% 1052
2019
Q4
$0 Hold
80
﹤0.01% 1035
2019
Q3
$0 Hold
80
﹤0.01% 1031
2019
Q2
$0 Hold
80
﹤0.01% 1028
2019
Q1
$0 Hold
80
﹤0.01% 1087
2018
Q4
$0 Hold
80
﹤0.01% 1103
2018
Q3
$0 Hold
80
﹤0.01% 971
2018
Q2
$0 Hold
80
﹤0.01% 1034
2018
Q1
$0 Hold
80
﹤0.01% 1073
2017
Q4
$0 Hold
80
﹤0.01% 1030
2017
Q3
$0 Hold
80
﹤0.01% 1022
2017
Q2
$0 Hold
80
﹤0.01% 966
2017
Q1
$0 Hold
80
﹤0.01% 980
2016
Q4
$0 Hold
80
﹤0.01% 997
2016
Q3
$0 Hold
80
﹤0.01% 938
2016
Q2
$0 Hold
80
﹤0.01% 939
2016
Q1
$0 Hold
80
﹤0.01% 921
2015
Q4
$0 Hold
80
﹤0.01% 930
2015
Q3
$0 Hold
80
﹤0.01% 928
2015
Q2
$1K Hold
80
﹤0.01% 890
2015
Q1
$1K Hold
80
﹤0.01% 885
2014
Q4
$1K Hold
80
﹤0.01% 888
2014
Q3
$1K Hold
80
﹤0.01% 887
2014
Q2
$1K Hold
80
﹤0.01% 889
2014
Q1
$1K Hold
80
﹤0.01% 919
2013
Q4
$1K Hold
80
﹤0.01% 879
2013
Q3
$1K Hold
80
﹤0.01% 867
2013
Q2
$1K Buy
+80
New +$624 ﹤0.01% 859

Other funds holding PDLI

WhitTier Trust Company's PDLI Position: Q4 2020 in Review

WhitTier Trust Company sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 80 shares.

WhitTier Trust Company first reported a position in PDLI in Q2 2013 and held it in 30 quarters. The position peaked at $1K in Q2 2015. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • WhitTier Trust Company reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • WhitTier Trust Company sold 80 PDL BioPharma, Inc. shares in Q4 2020.
  • WhitTier Trust Company first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 30 quarters.
  • WhitTier Trust Company's PDL BioPharma, Inc. position peaked at $1K in Q2 2015.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on WhitTier Trust Company's 13F filing for Q4 2020, filed 29 Jan 2021.